Literature DB >> 23946629

Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches.

Uche Anadu Ndefo, Angie Eaton, Monica Robinson Green.   

Abstract

Oral contraceptives, antidiabetes drugs, and statins are some of the therapies used to address the symptoms of this complex hormonal condition. Weight loss and surgery may also be beneficial as non-drug options.

Entities:  

Year:  2013        PMID： 23946629      PMCID： PMC3737989     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


  31 in total

Review 1.  Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.

Authors:  Thomas Tang; Jonathan M Lord; Robert J Norman; Ephia Yasmin; Adam H Balen
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  Polycystic ovary syndrome: a common but often unrecognized condition.

Authors:  Maureen Shannon; Yusharn Wang
Journal:  J Midwifery Womens Health       Date:  2012 May-Jun       Impact factor: 2.388

Review 3.  The role of genes and environment in the etiology of PCOS.

Authors:  Evanthia Diamanti-Kandarakis; Helen Kandarakis; Richard S Legro
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

4.  ACOG Practice Bulletin No. 108: Polycystic ovary syndrome.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-10       Impact factor: 7.661

5.  Statin is a reasonable treatment option for patients with Polycystic Ovary Syndrome: a meta-analysis of randomized controlled trials.

Authors:  L Gao; F-L Zhao; S-C Li
Journal:  Exp Clin Endocrinol Diabetes       Date:  2012-05-25       Impact factor: 2.949

6.  Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome.

Authors:  Katica Bajuk Studen; Miran Sebestjen; Marija Pfeifer; Janez Prezelj
Journal:  Eur J Endocrinol       Date:  2010-12-13       Impact factor: 6.664

Review 7.  Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.

Authors:  Cindy Farquhar; Julie Brown; Jane Marjoribanks
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

Review 8.  Polycystic ovarian syndrome: role of imaging in diagnosis.

Authors:  Tony T Lee; Mary E Rausch
Journal:  Radiographics       Date:  2012-10       Impact factor: 5.333

9.  Anastrozole or letrozole for ovulation induction in clomiphene-resistant women with polycystic ovarian syndrome: a prospective randomized trial.

Authors:  Ahmed Badawy; Abeer Mosbah; Magda Shady
Journal:  Fertil Steril       Date:  2007-08-08       Impact factor: 7.329

10.  Metabolic and endocrine effects of metformin and metformin plus cyclic medroxyprogesterone acetate in women with polycystic ovary syndrome.

Authors:  Bulent Haydardedeoglu; Erhan Simsek; Esra B Kilicdag; Tayfun Bagis
Journal:  Int J Gynaecol Obstet       Date:  2009-01-19       Impact factor: 3.561
View more
  30 in total

1.  Compromised endothelial function in transgender men taking testosterone.

Authors:  Barbara I Gulanski; Clare A Flannery; Patricia R Peter; Cheryl A Leone; Nina S Stachenfeld
Journal:  Clin Endocrinol (Oxf)       Date:  2019-12-13       Impact factor: 3.478

2.  Association of Prooxidant-Antioxidant Balance with Clinical and Laboratory Parameters and Its Relation to Different Drug Regimens in Polycystic Ovary Syndrome Women with Normal BMI.

Authors:  Niloofar Heshmati; Shoaleh Shahgheibi; Bahram Nikkhoo; Sabrieh Amini; Mohammad Abdi
Journal:  Indian J Clin Biochem       Date:  2016-08-31

Review 3.  Rate of polycystic ovary syndrome in mental health disorders: a systematic review.

Authors:  Katie M Douglas; Anna J Fenton; Kate Eggleston; Richard J Porter
Journal:  Arch Womens Ment Health       Date:  2021-09-09       Impact factor: 3.633

4.  Network Pharmacology-Based Strategy for Predicting Active Ingredients and Potential Targets of Coptis chinensis Franchin Polycystic Ovary Syndrome.

Authors:  Jian Xiong Ma; Miaoyong Ye; Ke Ma; Kang Zhou; Yingying Zhang; Xiting Wang; Hongxuan Tong
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-18       Impact factor: 2.629

Review 5.  Recent Advances in the Management of Polycystic Ovary Syndrome: A Review Article.

Authors:  Shivani Akre; Kapil Sharma; Swarupa Chakole; Mayur B Wanjari
Journal:  Cureus       Date:  2022-08-04

6.  A subpathway-based method of drug reposition for polycystic ovary syndrome.

Authors:  Hai-Ying Liu; Jian-Qiao Liu; Zi-Xin Mai; Yan-Ting Zeng
Journal:  Reprod Sci       Date:  2014-07-11       Impact factor: 3.060

7.  Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome.

Authors:  Büşra Başar Gökcen; Yasemin Akdevelioğlu; Sultan Canan; Nuray Bozkurt
Journal:  Eat Weight Disord       Date:  2020-08-08       Impact factor: 4.652

8.  Vascular compliance in women with polycystic ovary syndrome treated with spironolactone.

Authors:  Ozgul Muneyyirci-Delale; Sherilyne Co; Nathaniel Winer
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-09-14       Impact factor: 3.738

9.  Assessment the Correlations of Hormones, Lipid Profiles, Oxidative Stress, and Zinc Concentration in Iraqi Women with Polycystic Ovary Syndrome.

Authors:  Ashwaq Shenta; Khansaa Saud; Ali Al-Shawi
Journal:  Rep Biochem Mol Biol       Date:  2020-10

10.  Protective effects of berberine in a rat model of polycystic ovary syndrome mediated via the PI3K/AKT pathway.

Authors:  Jia Yu; Caifei Ding; Zhoujia Hua; Xuejuan Jiang; Chenye Wang
Journal:  J Obstet Gynaecol Res       Date:  2021-03-11       Impact factor: 1.730
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.